Properties
Description
Apratastat inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP.
Molecular Formula
C17H22N2O6S2
Identity
Confirmed by NMR/HPLC/MS.
Applications
Apratastat is an MMP inhibitor used in research to block matrix metalloproteinase activity, potentially useful in inflammatory and degenerative diseases.
